Assessing the toxicological significance of new psychoactive substances in fatalities.

about

Assessing the toxicological significance of new psychoactive substances in fatalities.

Item

http://www.wikidata.org/entity/Q48246805

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Assessing the toxicological significance of new psychoactive substances in fatalities.

@en

Assessing the toxicological significance of new psychoactive substances in fatalities.

@nl

type

Item

label

Assessing the toxicological significance of new psychoactive substances in fatalities.

@en

Assessing the toxicological significance of new psychoactive substances in fatalities.

@nl

prefLabel

Assessing the toxicological significance of new psychoactive substances in fatalities.

@en

Assessing the toxicological significance of new psychoactive substances in fatalities.

@nl

P1476

Assessing the toxicological significance of new psychoactive substances in fatalities

@en

P2093

Michael Evans-Brown

http://www.w3.org/2001/XMLSchema#string

Roumen Sedefov

http://www.w3.org/2001/XMLSchema#string

P2860

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.

Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre.

Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): human and animal data.

Drug harms in the UK: a multicriteria decision analysis.

AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis.

First reported fatalities associated with the 'research chemical' 2-methoxydiphenidine.

Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products.

Validation of new methods.

Methods for causality assessment of adverse drug reactions: a systematic review.

P304

120-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.2225

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon Elliott

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28635164

http://www.w3.org/2001/XMLSchema#string